Clinical News and Research

RSS

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

Michigan's Oncology Sequencing Program, or MiOncoSeq, was the first of its kind in the nation to sequence patient tumors.

24 Oct 2026

New Genetic Map Identifies Variations Linked to Long QT Syndrome

Using an innovative, high-throughput technique, an international collaboration led by Vanderbilt Health researchers has created a "map" of 1,757 genetic variations that can trigger a life-threatening heart rhythm disorder called long QT syndrome.

24 Oct 2026

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Evaxion A/S, a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immune and clinical outcome data for personalized cancer vaccine EVX-01 in patients with advanced melanoma.

From Evaxion A/S 24 Oct 2026

Carrier-Free Jet Vaccine Method Protects Against COVID-19 and Flu in Animal Studies

A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.

24 Oct 2026

BioUK Awards 2026 Celebrate Outstanding Achievement and Breakthrough Innovations from Across the Life Sciences

BioUK, the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.

From BioUK 23 Oct 2026

BioNTech Opens mRNA Manufacturing Facility at La Trobe

La Trobe University is now home to one of the world’s leading biopharmaceutical companies, with the official opening of BioNTech’s state-of-the-art, clinical-scale mRNA manufacturing and research facility at the University’s campus in Melbourne’s north.

From BioNTech SE 22 Oct 2026

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

Metabolic Reprogramming Enhances Gamma Delta CAR T Solid Tumor Clearance

By turning a patient's own immune cells into stronger cancer-fighting cells, CAR T-cell therapy has transformed how some blood cancers are treated. But it's been harder to extend this approach to solid tumors, including cancer that has spread to the bone.

21 Oct 2026

Clinician-Led Approach Could Give Doctors a Control Dial for Cell Therapies

A clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.

20 Oct 2026

Regular Hot Baths Could Alleviate Common Circulatory Disease

A regular soak in a hot bath could help to improve a common painful circulatory disease, with this strategy being studied by researchers at Manchester Metropolitan University, thanks to funding from the British Heart Foundation.

20 Oct 2026

Millions of Older Australians Exposed to Overlapping Medication Risks

An estimated 2.3 million older Australians are being dispensed multiple medicines associated with falls and fractures, while more than 1.2 million are receiving combinations linked to kidney-related side effects, according to new research from Adelaide University.

20 Oct 2026

Dendritic Cell STING Activation Licenses Cytotoxic T Lymphocyte Priming

Immune checkpoint inhibitors (ICIs) have transformed cancer care, yet only a subset of patients benefit. A major barrier is tumor microenvironment (TME) heterogeneity: "hot" tumors are enriched with cytotoxic T lymphocytes (CTLs) and respond better, while "cold" tumors lack T-cell infiltration or are shielded by immunosuppressive barriers.

20 Oct 2026

Stable Isotope Carbon Tracing Proves Uncoupling Inhibits De Novo Purine Synthesis

Mitochondrial serine catabolic pathway (MSCP), also called serine, glycine, and one-carbon metabolism, is essential for cancer cells to produce amino acids, one-carbon units, and reducing equivalents.

20 Oct 2026

Live Organelle Imaging Catches Early Neuronal Stress Before Cell Death

Scientists studying amyotrophic lateral sclerosis (ALS), Parkinson's, Alzheimer's and other neurological diseases are getting unprecedented views inside brain cells, using powerful new microscopes to uncover changes that may begin long before neurons die.

20 Oct 2026

In Situ Plasmonic Nanostructure Growth Enables Label Free Bacterial SERS Analysis

A research team led by Senior Researcher Minyoung Lee and Principal Researcher Sunggyu Park of the Advanced Bio and Healthcare Materials Research Division at the Korea Institute of Materials Science (KIMS), headed by President Chul-jin Choi, has developed a label-free surface-enhanced Raman scattering (SERS) analysis technology that rapidly detects extremely low concentrations of viable bacteria by directly growing plasmonic metal nanostructures on and around bacterial cells.

20 Oct 2026

Mayo Clinic Study Advances Detection of Somatic DNA Mutations

Researchers in a Mayo Clinic-led study have shown how to detect a broad range of DNA mutations in noncancerous human tissues and across the genome.

16 Oct 2026

Three Genes Identified to Prioritize Genetic Drug Testing in China

A research team has identified three genes that could help prioritize pharmacogenomic testing for older adults in China who receive multiple medications.

16 Oct 2026

AI Partnership Aims to Personalize IVF Treatment, Improve Patient Outcomes

La Trobe University and reproductive health innovator GonGlobal have entered into a strategic collaboration to develop and validate advanced artificial intelligence (AI) and digital twin technologies for Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF).

16 Oct 2026

Food Allergy Risk Changes as Children Grow

Sensitization to food allergens can change considerably during the first five years of a child’s life. A large Canadian birth-cohort study shows that sensitization to peanut often develops early and persists, while sensitization to several tree nuts tends to appear later.

16 Oct 2026

Naturally Occurring Protein Balances Immune Protection and Excessive Tissue Inflammation

A naturally occurring protein can help the immune system fight viral infections while also reducing the damaging inflammation that often accompanies them, a new study from McMaster University has found.

16 Oct 2026

Clinical News and Research

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

New Genetic Map Identifies Variations Linked to Long QT Syndrome

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Carrier-Free Jet Vaccine Method Protects Against COVID-19 and Flu in Animal Studies

BioUK Awards 2026 Celebrate Outstanding Achievement and Breakthrough Innovations from Across the Life Sciences

BioNTech Opens mRNA Manufacturing Facility at La Trobe

INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar

Metabolic Reprogramming Enhances Gamma Delta CAR T Solid Tumor Clearance

Clinician-Led Approach Could Give Doctors a Control Dial for Cell Therapies

Regular Hot Baths Could Alleviate Common Circulatory Disease

Millions of Older Australians Exposed to Overlapping Medication Risks

Dendritic Cell STING Activation Licenses Cytotoxic T Lymphocyte Priming

Stable Isotope Carbon Tracing Proves Uncoupling Inhibits De Novo Purine Synthesis

Live Organelle Imaging Catches Early Neuronal Stress Before Cell Death

In Situ Plasmonic Nanostructure Growth Enables Label Free Bacterial SERS Analysis

Mayo Clinic Study Advances Detection of Somatic DNA Mutations

Three Genes Identified to Prioritize Genetic Drug Testing in China

AI Partnership Aims to Personalize IVF Treatment, Improve Patient Outcomes

Food Allergy Risk Changes as Children Grow

Naturally Occurring Protein Balances Immune Protection and Excessive Tissue Inflammation

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

RecentIndustryFocuses

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics